Department of Neuroscience & Movements Science, Section of Medicine, University of Fribourg, Fribourg, Switzerland.
Department of Psychiatry, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Mol Autism. 2020 Jan 29;11(1):10. doi: 10.1186/s13229-020-0314-0.
Autism spectrum disorders (ASD) are persistent conditions resulting from disrupted/altered neurodevelopment. ASD multifactorial etiology-and its numerous comorbid conditions-heightens the difficulty in identifying its underlying causes, thus obstructing the development of effective therapies. Increasing evidence from both animal and human studies suggests an altered functioning of the parvalbumin (PV)-expressing inhibitory interneurons as a common and possibly unifying pathway for some forms of ASD. PV-expressing interneurons (short: PVALB neurons) are critically implicated in the regulation of cortical networks' activity. Their particular connectivity patterns, i.e., their preferential targeting of perisomatic regions and axon initial segments of pyramidal cells, as well as their reciprocal connections, enable PVALB neurons to exert a fine-tuned control of, e.g., spike timing, resulting in the generation and modulation of rhythms in the gamma range, which are important for sensory perception and attention.New methodologies such as induced pluripotent stem cells (iPSC) and genome-editing techniques (CRISPR/Cas9) have proven to be valuable tools to get mechanistic insight in neurodevelopmental and/or neurodegenerative and neuropsychiatric diseases. Such technological advances have enabled the generation of PVALB neurons from iPSC. Tagging of these neurons would allow following their fate during the development, from precursor cells to differentiated (and functional) PVALB neurons. Also, it would enable a better understanding of PVALB neuron function, using either iPSC from healthy donors or ASD patients with known mutations in ASD risk genes. In this concept paper, the strategies hopefully leading to a better understanding of PVALB neuron function(s) are briefly discussed. We envision that such an iPSC-based approach combined with emerging (genetic) technologies may offer the opportunity to investigate in detail the role of PVALB neurons and PV during "neurodevelopment ex vivo."
自闭症谱系障碍(ASD)是由神经发育障碍引起的持续性疾病。ASD 的多因素病因及其众多合并症增加了确定其根本原因的难度,从而阻碍了有效治疗方法的发展。越来越多的动物和人类研究证据表明,抑制性中间神经元表达的 parvalbumin(PV)功能改变是某些形式的 ASD 的共同且可能统一的途径。表达 PV 的中间神经元(简称:PVALB 神经元)对皮质网络活动的调节具有重要意义。它们特定的连接模式,即它们优先靶向锥体神经元的体区和轴突起始段,以及它们的相互连接,使 PVALB 神经元能够对例如尖峰时间进行微调控制,从而产生和调制伽马范围内的节律,这对于感觉感知和注意力很重要。诱导多能干细胞(iPSC)和基因组编辑技术(CRISPR/Cas9)等新方法已被证明是深入了解神经发育和/或神经退行性和神经精神疾病的机制的有价值的工具。这些技术进步使我们能够从 iPSC 中产生 PVALB 神经元。对这些神经元进行标记,可以在从前体细胞到分化(和功能)的 PVALB 神经元的发育过程中跟踪它们的命运。此外,它还可以使用来自健康供体的 iPSC 或具有 ASD 风险基因已知突变的 ASD 患者的 iPSC,更好地理解 PVALB 神经元的功能。在这篇概念论文中,简要讨论了有望更好地理解 PVALB 神经元功能的策略。我们设想,这种基于 iPSC 的方法与新兴的(遗传)技术相结合,可能有机会详细研究 PVALB 神经元和 PV 在“体外神经发育”中的作用。